Central	B:C1533734
apelin-13	I:C1533734
administration	I:C1533734
modulates	B:C0443264
hypothalamic	B:C0020663
control	O
of	O
feeding	B:C0013470
.	O

The	O
77	O
amino	B:C1531139
prepropeptide	I:C1531139
apelin	I:C1531139
has	O
been	O
isolated	O
from	O
bovine	B:C3667982
stomach	B:C0038351
tissue	B:C0040300
and	O
several	O
smaller	O
fragments	B:C0486805
,	O
including	O
apelin	B:C3179318
-	I:C3179318
13	I:C3179318
,	O
showed	O
high	O
affinity	O
for	O
the	O
orphan	B:C1137482
APJ	I:C1137482
receptor	I:C1137482
.	O

The	O
distribution	O
of	O
apelinergic	B:C0033684
fibers	I:C0033684
and	O
receptors	B:C1137482
in	O
the	O
hypothalamus	B:C0020663
may	O
suggest	O
a	O
role	O
of	O
apelin	B:C3179318
-	I:C3179318
13	I:C3179318
on	O
energy	O
balance	O
regulation	O
,	O
albeit	O
the	O
studies	B:C2603343
reporting	B:C0011000
the	O
acute	O
effects	O
of	O
apelin	B:C3179318
on	O
feeding	B:C0013470
control	O
are	O
inconsistent	O
.	O

Considering	O
the	O
possible	B:C0332149
involvement	O
of	O
apelinergic	B:C0460002
system	I:C0460002
on	O
hypothalamic	B:C0003618
appetite	I:C0003618
controlling	O
network	O
,	O
in	O
the	O
present	O
study	B:C2603343
we	O
evaluated	O
in	O
the	O
rat	B:C0034721
the	O
effects	O
of	O
intrahypothalamic	B:C1533685
apelin	I:C1533685
-	I:C1533685
13	I:C1533685
injection	I:C1533685
on	O
food	B:C0013470
intake	I:C0013470
and	O
the	O
involvement	O
of	O
orexigenic	B:C0574031
and	O
anorexigenic	B:C0574031
hypothalamic	I:C0574031
peptides	I:C0574031
and	O
neurotransmitters	B:C0027908
.	O

Eighteen	O
rats	B:C0034721
(	O
6	O
for	O
each	O
group	O
of	O
treatment	B:C0087111
)	O
were	O
injected	O
into	O
the	O
ARC	B:C1138248
with	O
either	O
vehicle	B:C0042444
or	O
apelin	B:C3179318
-	I:C3179318
13	I:C3179318
(	O
1	O
-	O
2	O
Î¼g/	O
rat	B:C0034721
)	O
.	O

Food	B:C0013470
intake	I:C0013470
and	O
hypothalamic	B:C0030956
peptide	I:C0030956
and	O
neurotransmitter	B:C0027908
levels	O
were	O
evaluated	O
2	O
and	O
24	O
h	O
after	O
injection	B:C1272883
.	O

Compared	O
to	O
vehicle	B:C0042444
,	O
apelin	B:C3179318
-	I:C3179318
13	I:C3179318
administration	B:C1533734
increased	O
food	B:C0013470
intake	I:C0013470
both	O
2	O
and	O
24	O
h	O
following	O
treatment	B:C0087111
.	O

This	O
effect	O
could	O
be	O
related	O
to	O
inhibited	O
cocaine	B:C1824528
-	I:C1824528
and	I:C1824528
amphetamine	I:C1824528
-	I:C1824528
regulated	I:C1824528
transcript	I:C1824528
(	O
cocaine	B:C1824528
-	I:C1824528
and	I:C1824528
amphetamine	I:C1824528
-	I:C1824528
regulated	I:C1824528
transcript	I:C1824528
)	O
gene	B:C0017262
expression	I:C0017262
and	O
serotonin	B:C0036751
(	O
5	B:C0036751
-	I:C0036751
hydroxytryptamine	I:C0036751
,	O
5	B:C0036751
-	I:C0036751
HT	I:C0036751
)	O
synthesis	B:C1154450
and	O
release	O
,	O
and	O
increased	O
orexin	B:C0671870
A	I:C0671870
gene	B:C0017262
expression	I:C0017262
in	O
the	O
hypothalamus	B:C0020663
.	O

